Vietnam Health Official Warns Drug Makers Against Price Increases
This article was originally published in PharmAsia News
The chief inspector of Vietnam's Ministry of Health warned drug makers they will be fined or have their licenses revoked if they increase prices without authorization. The inspector said his office plans to keep an eye on hospitals to be sure the supplies they need are delivered and to ensure there is no withholding of drugs by manufacturers expecting the price to increase later. A ban on price increases expired June 30, but the ministry still must act on requests for higher prices submitted by drug firms. (Click here for more
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.